News 2020-09-18
Porton Received Certificate of Appreciation from Ethiopian Ministry of Health
Recently, Porton Pharma Solutions Ltd has received Certificate of Appreciation from Ethiopian Ministry of Health for Porton’s immense support and outstanding contribution on fighting against COVID-19 with donation of masks. This donation will help healthcare workers in their daily duty in combating the spread of the virus in Ethiopia.
Every company must have a sense of social responsibility, so Porton is willing to contribute its modest and small efforts to show the kindness from China in the ongoing global public health crisis. We will continue to support the global fight against COVID-19.
Others
More
News 2025-04-16
Porton Advanced's End-to-End CDMO Solutions Accelerates IND Approval of Tasly's Innovative Dual-Targeting CAR-T Therapy
April 12, 2025 - Porton Advanced proudly announces its CDMO support for TASLY PHARMACEUTICAL CO., LTD’s Innovative Dual-Targeting CAR-T Therapy, "P134 Cell Injection," which has received Investigational New Drug (IND) approval from China's National Medical Products Administration (NMPA) (Approval No.: 2025LP01030). This breakthrough CAR-T therapy is indicated for recurrent glioblastoma (GBM).

News 2025-04-11
Porton Newsletter - Q1 2025 Recap
Technical Enabling Services & Solutions Company Events ESG Marketing Activities